2d
MedPage Today on MSNHigh Price of GLP-1 Agents Tip Cost-Benefit Scale UnfavorablyTirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
5d
Verywell Health on MSNNovo Nordisk Offers Wegovy for $499 a Month in Direct-to-Consumer ProgramNovo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management.
Vivani Medical, Inc. ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the successful administration of its ...
Novo Nordisk released clinical trial results on Monday for its potential Ozempic successor, but for the second time, it fell short of analysts’ expectations, disappointing Wall Street.
Customers can expect a rate hike up to 14 percent as employee welfare costs surge related to Ozempic and drugs like it.
2d
Woman's World on MSNStudy: Postmenopausal Women Lose More Weight With GLP-1 and HRTIt seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...
2-Year U.S. Treasury Note Continuous Contract $103.473 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $107.750 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $110.688 0.047 ...
The latest League of Legends patch promises to shake up things after the First Stand professional tournament. With how the recent changes have been represented at the professional level, Riot ...
After hours: March 14 at 7:59:33 PM EDT Loading Chart for O ...
5-Year U.S. Treasury Note Continuous Contract $107.992 0.086 0.08% 10-Year U.S. Treasury Note Continuous Contract $110.969 0.125 0.11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results